These compounds may interact with:

Dual specificity mitogen-activated protein kinase kinase 1

Potentially involved in: cardiomyopathy; cardiofaciocutaneous syndrome; intellectual disability; lung cancer; leopard syndrome; langerhans-cell histiocytosis; noonan syndrome; melanoma; kidney cancer; carcinoma; skin cancer; cancer; costello syndrome; vascular disease; erdheim-chester disease; aortic coarctation; blepharoptosis; hypertrophic cardiomyopathy; brain ischemia; cryptorchidism

Disease data sourced from Pharos.